Latest Updates
-
Alia Bhatt's Ethnic Outfits Stole Every Spotlight At Best Friend Akansha Ranjan Kapoor's Wedding Celebrations -
Jagannath Rath Yatra 2026: 10 Iconic Odia Delicacies Every Visitor Must Try In Puri -
Katrina Kaif Shares Birthday Dump, Gives Glimpse Of Baby Vihaan: 10 Little Details Worth A Closer Look -
Sita Vs Shurpanakha! Sai Pallavi And Rakul Preet Singh's Sarees Ruled The Ramayana Pratham Sankalp Event -
National Film Awards 2026: From Yami Gautam's Big Win To Dhanush's Double Triumph—7 Biggest Takeaways -
Things To Do In The Rain: 10 Cozy Monsoon Ideas That Will Make You Love Rainy Days Even More -
Sarcoma Awareness Month 2026: Can A Sports Injury Hide Sarcoma? Medical Oncologist Explains The Warning Signs -
Who Is Gitanjali J. Angmo? Why Sonam Wangchuk's Wife's Statement On His Treatment Is Making Headlines -
Jennifer Winget's Viral Bridal Gown Trial Video Reveals The Intricate Details Behind Her Bespoke Couture Look -
Happy Birthday Bhumi Pednekar: How Rishikesh, Pushkar And Meditation Helped The Actress Find Inner Peace
Cancer-Inhibiting Compound Found Under The Sea

University of Florida College of Pharmacy researchers claim to have found a marine compound that can halt cancer progression.
The researchers say that the compound found off the cost of Key Largo has been found to inhibit cancer cell growth in laboratory tests, giving hope that new drugs to better battle the disease may soon be available.
A presentation on the efficacy of the UF-patented compound largazole, derived from cyanobacteria that grow on coral reefs, was made at an international natural products scientific meeting in Athens, Greece.
Experts attending the meeting described largazole as one of the most promising they had found since the college's marine natural products laboratory was established three years ago.
"It's exciting because we've found a compound in nature that may one day surpass a currently marketed drug or could become the structural template for rationally designed drugs with improved selectivity," said Dr. Hendrik Luesch, an assistant professor in UF's department of medicinal chemistry, and the principal investigator on the study.
A research article in the Journal of the American Chemical Society reveals that largazole, discovered and named by Luesch for its Florida location and structural features, seeks out a family of enzymes called histone deacetylase (HDAC).
Background information in the article suggests that over-activity of certain HDACs is associated with several cancers like prostate and colon tumours, and inhibiting them can activate tumour-suppressor genes that have been silenced in these cancers.
Luesch says that a largazole-based drug might result in improved therapies and fewer side effects, given that this compound does not inhibit all HDACs equally.
His team has now joined forces with Jiyong Hong, an assistant professor in the department of chemistry at Duke University, to conduct further biological testing on the compound.
Luesch has revealed that, within the next few months, he plans to study whether largazole reduces or prevents tumour growth in mice.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications